RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Argument Pharma

Company

Content

History

2021: Launch of production of vital drugs for 1.5 billion rubles in the Dubna SEZ

At the end of July 2021, it became known that the Argum Pharma company, in the status of a resident of the Dubna SEZ, will be engaged in the production of sterile ready-made medicines, including those included in the list of vital and important medicines. Investments in the project amount to 1.5 billion rubles.

Argum Pharma plans to create about 120 new jobs. The company rents a land plot in the Dubna SEZ, with a total area of ​ ​ about 2.3 hectares, on which a laboratory and production complex with a total area of ​ ​ at least 9.2 thousand square meters will be built.

Resident of the Dubna SEZ Argum Pharma launches the production of vital drugs for 1.5 billion rubles

Drugs manufactured by the company can be used:

  • to stabilize blood pressure in surgical interventions;
  • in arterial hypertension, tachycardia, myocardial infarction;
  • in pain syndrome, including for pain relief in childbirth.

The Ministry of Investment, Industry and Science of the Moscow Region noted that among the company's products there will be analogues of foreign drugs. The goal of the project is the import substitution of foreign analogues with more accessible products of domestic production, not inferior to them in quality, the department added.

File:Aquote1.png
For Argumum Pharma LLC, all this [preferences from placing SEZ production] will significantly reduce costs at the stage of development and introduction into the production of a drug and, as a result, reduce the cost of products, which will lead to lower prices for the country's population for important drugs, "said Ekaterina Zinovieva, Minister of Investment, Industry and Science of the Moscow Region.
File:Aquote2.png

According to the SPARK-Interfax system, Argumum Pharma LLC was registered in the Dubna city district in early May 2021 and is 100% owned by businessman Oleg Levchenko. The company specializes in the production of medicines and materials used for medical purposes. The authorized capital of the legal entity is 100 thousand rubles.[1]

Notes